Clinical impact of removing respiratory motion during liver SABR.

Maegan A GargettC HaddadA KneeboneJ T BoothN Hardcastle

Published in: Radiation oncology (London, England) (2019)

In liver SABR treatments unable to be prescribed optimal dose due to exceeding mean liver thresholds, eliminating respiratory motion allowed dose escalation in the majority of patients studied and substantially increased TCP.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
peritoneal dialysis
prognostic factors
patient reported outcomes
respiratory tract
mass spectrometry
patient reported